The largest database of trusted experimental protocols

9 protocols using desmin clone d33

1

Immunohistochemical Profiling of FFPE Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed paraffin-embedded tissue (FFPE) sections were immunostained with rabbit primary antibodies against NF-κB p65, alpha smooth muscle actin (α-SMA) and desmin. In the immunohistochemical (IHC) protocol, 4 μm thick FFPE slides were deparaffinized and rehydrated with xylene and ethanol. Antigen retrieval was applied by boiling the slides in the triplicates (Cell Marque, Rocklin, CA, USA) in a microwave at 95 °C for 10 min. The slides were then incubated with 10% protein-blocking normal goat and rabbit sera (Dako, Glostrup, Denmark) for 30 min to reduce non-specific binding. Antigen expression was detected by primary antibodies against rabbit polyclonal NF-κB p65 (clone ab86299, 1 in 200 dilution; Abcam, Cambridge, MA, USA), α-SMA (clone 1A4, 1 in 200 dilution; Dako) and desmin (clone D33, 1 in 200 dilution; Dako) for 1 h. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide (KYB, New Taipei City, Taiwan) for 15 min. Afterward, primary antibodies were detected using a REAL Envision kit (Dako) using diaminobenzidine as a chromogenic substrate. The slides were finally counterstained with hematoxylin (Muto Pure Chemicals, Tokyo, Japan) for 15 s. Substitution of primary antibody with antibody diluent was performed as a negative control.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of FFPE Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four µm-thick serial sections were cut from the formalin-fixed paraffin-embedded (FFPE) tumour blocks and were used for haematoxylin and eosin (HE) staining and immunohistochemical analysis. HE staining was performed according to standard protocols.
Slides of tumour were de-paraffinized in xylene, hydrated in alcohol and baked in a microwave. Endogenous peroxidase was blocked. Immunohistochemical analysis was performed in all cases with the following antibodies: desmin (clone D33, Dako), myogenin (clone LO26, Novacastra), transgelin (clone D33, LSBio, Seattle, WA, United States) and caldesmone (clone h-CD, Dako). Appropriate positive and negative controls for each antibody were included. Pictures were captured using a Zeiss Cell Observer Microscope (Zeiss).
+ Open protocol
+ Expand
3

Comprehensive Immunohistochemistry Panel for Tumor Diagnosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cases were identified in the consultation files of the authors. The tissue specimens were fixed in formalin and processed routinely for histopathology. Immunohistochemistry (IHC) was performed on 3-μm sections cut from paraffin blocks using a fully automated system (“Benchmark XT System”, Ventana Medical Systems Inc., 1910 Innovation Park Drive, Tucson, Arizona, USA) and the following antibodies: vimentin (V9, 1:100, Dako), keratin cocktail (clone AE1/AE3, 1:40, Zytomed, Berlin, Germany), p63 (SSI6, 1: 100, DCS), desmin (clone D33, 1:250, Dako), alpha smooth muscle actin (clone 1A4, 1:200, Dako), HMB45 (clone HMB45, 1:50, Enzo), Melan A (clone A103, 1:50, Dako), CD34 (clone BI-3C5, 1:200, Zytomed), ERG (EPR3864, prediluted, Ventana), CD31 (clone JC70A, 1:20, Dako), S100 protein (polyclonal, 1:2500, Dako), SOX10 (polyclonal, 1:25, DCS), PAX8 (polyclonal rabbit anti-PAX8, 1:50, Cell Marque), NSE (clone BBS/NC/VI-H1, 1:300, Dako), TTF1 (clone 8G7G3/1, 1:500, Zytomed Systems, Berlin, Germany), Napsin A (MRQ-60, ready-to-use, Medac), calretinin (polyclonal, 1:100, Zytomed), alpha-inhibin (clone R1, 1:50, Serotec), GFAP (Clone GFA, 1/1000, DakoPatts, Denmark), EMA (clone E29, 1:200, Dako), STAT6 (clone S-20, 1:1000, Santa Cruz Biotechnology), TFE3 (clone MRQ-37, 1:100, Cell Marque), Cathepsin-K (clone 3F9, 1:50, Abcam) and Ki67 (clone MiB1, 1:100, Dako).
+ Open protocol
+ Expand
4

Comprehensive Immunohistochemistry Panel for Sinonasal Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry for CD99 (clone 12E7; Leica, Buffalo Grove, IL; prediluted), pancytokeratin (PCK26; Ventana, Tuscon, AZ; prediluted); p40 (Ab-1; Oncogene Research Products, Cambridge, MA; 1:2000 dilution), synaptophysin (clone 27G12; Leica Microsystems; prediluted); chromogranin (clone LK2H10; Ventana; prediluted); S100 protein (clone 4C4.9; Ventana; prediluted), muscle specific actin (clone HHF35; Ventana, prediluted); desmin (clone D33, Dako, Carpinteria, CA; 1:100 dilution), NUT-1 (clone C52B1, Cell Signaling Technologies, Inc., Danvers, MA, 1:50 dilution), and p16 (clone INK4a; MTM Laboratories, Heidelberg, Germany); was performed on five-micron sections utilizing standard protocols on a Ventana Benchmark XT autostainer. In addition, in situ hybridization for high-risk types of human papillomavirus was also performed utilizing the Ventana HR HPV III probe set that captures HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 66. The sinonasal tissue microarray was also stained with CD99.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical analysis was performed on formalin-fixed, paraffin-embedded tissue using the Dako Envision Plus detection system (Dako, Carpinteria, CA, USA) with controls. The antibodies used included MDM2 (clone SMP14, ready-to-use; Abcam, Cambridge, UK), CDK4 (clone EP180, 1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA), S-100 protein (clone 4C49, 1:100; Abcam, Cambridge, UK), CD34 (clone QBEnd 10, 1:100; Abcam, Cambridge, UK), desmin (clone D33, 1:100; Dako, Carpinteria, CA, USA), smooth muscle actin (SMA) (clone 1A4, 1:100; Dako, Carpinteria, CA, USA), H-caldesmon (clone h-CD, 1:100; Dako, Carpinteria, CA, USA), and p53 (clone Do-7, ready-to-use; Dako, Carpinteria, CA, USA).
+ Open protocol
+ Expand
6

Isolation of Tumor and Normal Gland Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Crypts were isolated from tumor and normal tissues, as described previously, to obtain pure tumor glands separately from the surrounding stromal tissues (23 (link)–25 (link)). Tumor glands were isolated from the solid tumor region involved in the invasion front, and this involvement was confirmed using tissue sections prepared for the pathological diagnosis. Gland cells were obtained from the tumor tissues after careful separation of the stromal cells (i.e. CAFs) adjacent to the glands, performed under a dissecting microscope. Cells from normal fallopian tube tissue and normal fibroblasts within the Fallopian tubes were also obtained as controls. Paraffin-embedded tissue sections of the isolated samples were routinely processed to confirm the histology. Immunostaining using antibodies against smooth muscle actin (clone 1A4; Dako) and desmin (clone D33; Dako) was performed in the stromal cells to confirm the exclusive presence of fibroblasts, determined according to negative staining of smooth muscle actin and positive staining of desmin. However, we could not exclude the possibility of stromal cell contamination with other non-epithelial cells, such as inflammatory and vessel cells. Representative images are shown in Fig. 1.
+ Open protocol
+ Expand
7

Histopathological and Immunohistochemical Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The surgical specimen was fixed in formalin and embedded routinely for histopathological evaluation. Hematoxylin and eosin (H&E) stained slides were prepared for histopathological examination and immunohistochemical staining was performed on 1 µm thick sections using an automated platform (Benchmark Ultra, Ventana Medical Systems Inc., Tucson, Arizona, U.S.A.) and the following antibodies: CD34 (clone QBEND-10; 1:50, Immunotech), smooth muscle actin (clone 1A4, 1:400, Dako), desmin (clone D33, 1:50, Dako), MyoD1 (clone 5.8A, 1:50, Dako), myogenin (clone F5D, 1:50, Dako), S100 (clone 4C4.9, 1:3000, Zytomed), MDM2 (clone IF2, 1:50, Calbiochem), CDK4 (clone DCS-156, 1:100, Zytomed), Retinoblastoma-1 (clone G3-245, 1:100, BD Pharmingen), CD10 (clone 56C6, 1:20, Zytomed), STAT6 (clone S-20, 1:1000, Santa Cruz) and SATB2 (clone EPNCIR130A, 1:200, abcam).
+ Open protocol
+ Expand
8

Comprehensive Immunohistochemical Analysis of Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The biopsy specimen was fixed in buffered formalin and embedded in paraffin for routine histological examination. Immunohistochemical studies were performed on 3-µm sections cut from paraffin blocks using a fully automated system ("Benchmark XT System", Ventana Medical Systems Inc., 1910 Innovation Park Drive, Tucson, Arizona, USA) and the following antibodies: pan cytokeratin (clone AE1/AE3, 1 : 40, Zytomed, Berlin, Germany), vimentin (V9, 1 : 100, Dako, Hamburg, Germany), CK7 (clone OV-TL, 1 : 1000, Biogenex), CK18 (clone CY-90, 1 : 500, Sigma), CK5 (clone XM26, 1 : 50, Zytomed), TTF-1 (clone 8G7G3/1, dilution, 1 : 500, Zytomed), ERG (clone EPR3864, prediluted/ ready to use, Ventana Medical Systems), CD31 (clone JC70A, 1 : 20, Dako), CD10 (clone 56C6, 1 : 20, Dako), p63 (clone SFI-6, 1 : 100, DCS), desmin (clone D33, 1 : 250, Dako), α-smooth muscle actin (clone 1A4, 1 : 200, Dako), S100 protein (polyclonal, 1 : 2500, Dako), CD34 (clone BI-3C5, 1 : 200, Zytomed), CD30 (clone Ber-H2, 1 : 40, Zytomed), MUC4 (clone EP256, 1:500, Epitomics), TLE1 (polyclonal, 1 : 200, Santa Cruz), STAT6 (clone sc-621, 1 : 1000, Santa Cruz Biotechnology), and SMARCB1 (INI1) (MRQ-27, 1 : 50, Zytomed), according to the manufacturer instructions.
+ Open protocol
+ Expand
9

Immunohistochemical Profiling of Tumor Specimens

Check if the same lab product or an alternative is used in the 5 most similar protocols
All tumour specimens had been fixed in buffered formalin overnight and processed routinely for histological assessment. Immunohistochemistry, on 3 μm sections cut from paraffin blocks, was performed using a fully automated Benchmark XT System (Ventana Medical Systems, Tucson, AR, USA) and the following antibodies: pan-cytokeratin (clone AE1/AE3, 1:40, Zytomed); CK7 (OV-TL, 1:1000, Biogenex); vimentin (V9, 1:100, Dako); desmin (clone D33, 1:250, Dako); α-smooth muscle actin (clone 1A4, 1:200, Dako); h-caldesmon (clone h-CD, 1:100, Dako); protein S-100 (polyclonal, 1:2500, Dako); CD34 (clone BI-3C5, 1:200, Zytomed); ERG (EPR3864, prediluted, Ventana); myogenin (clone F5D, 1:50, Dako); and STAT6 (clone sc-621, 1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!